SPL 1.60% 9.6¢ starpharma holdings limited

Ann: Positive final DEP irinotecan Phase 2 clinical trial results, page-8

  1. 4,870 Posts.
    lightbulb Created with Sketch. 262
    Well! Here We Go finally results that can be partnered with big Pharma for big bucks, these results are too good and will be gobbled up and fast tracked, not only are they better than current treatments they are also effective in currently unmet needs. Game changer results and a major move forward in dendrimer science and acceptance I would expect. I think Starpharma is finally on the way back and I am looking forward to second half of 2024 bring it on Cheryl.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.6¢
Change
0.002(1.60%)
Mkt cap ! $39.38M
Open High Low Value Volume
9.4¢ 9.6¢ 9.4¢ $32.09K 339.3K

Buyers (Bids)

No. Vol. Price($)
1 3699 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 65000 1
View Market Depth
Last trade - 13.54pm 06/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.